Patents by Inventor Ozlem O. Karakus

Ozlem O. Karakus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and method for dual targeting in treatment of neuroendocrine tumors
    Patent number: 11351137
    Abstract: Chemical compositions and methods of synthesis thereof. The compositions disclosed and described herein are directed toward thyroid hormone ?v?3 integrin receptor antagonists conjugated to targets of the norepinephrine transporter (NET) or the catecholamine transporter. The compositions have a dual targeting effect and increased targeting efficiency in the treatment and diagnostic imaging of neuroendocrine tumors.
    Type: Grant
    Filed: June 7, 2021
    Date of Patent: June 7, 2022
    Assignee: NANOPHARMACEUTICALS LLC
    Inventors: Shaker Mousa, Mehdi Rajabi, Ozlem O. Karakus
  • COMPOSITION AND METHOD FOR DUAL TARGETING IN TREATMENT OF NEUROENDOCRINE TUMORS
    Publication number: 20210299262
    Abstract: Chemical compositions and methods of synthesis thereof. The compositions disclosed and described herein are directed toward thyroid hormone ?v?3 integrin receptor antagonists conjugated to targets of the norepinephrine transporter (NET) or the catecholamine transporter. The compositions have a dual targeting effect and increased targeting efficiency in the treatment and diagnostic imaging of neuroendocrine tumors.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 30, 2021
    Inventors: Shaker Mousa, Mehdi Rajabi, Ozlem O. Karakus
  • Composition and method for dual targeting in treatment of neuroendocrine tumors
    Patent number: 11077082
    Abstract: Chemical compositions and methods of synthesis thereof. The compositions disclosed and described herein are directed toward thyroid hormone ?v?3 integrin receptor antagonists conjugated to targets of the norepinephrine transporter (NET) or the catecholamine transporter. The compositions have a dual targeting effect and increased targeting efficiency in the treatment and diagnostic imaging of neuroendocrine tumors.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: August 3, 2021
    Assignee: NANOPHARMACEUTICALS, LLC
    Inventors: Shaker Mousa, Mehdi Rajabi, Ozlem O. Karakus
  • COMPOSITION AND METHOD FOR DUAL TARGETING IN TREATMENT OF NEUROENDOCRINE TUMORS
    Publication number: 20190314314
    Abstract: Chemical compositions and methods of synthesis thereof. The compositions disclosed and described herein are directed toward thyroid hormone ?v?3 integrin receptor antagonists conjugated to targets of the norepinephrine transporter (NET) or the catecholamine transporter. The compositions have a dual targeting effect and increased targeting efficiency in the treatment and diagnostic imaging of neuroendocrine tumors.
    Type: Application
    Filed: April 30, 2019
    Publication date: October 17, 2019
    Inventors: Shaker Mousa, Mehdi Rajabi, Ozlem O. Karakus
  • Composition and method for dual targeting in treatment of neuroendocrine tumors
    Patent number: 10328043
    Abstract: Chemical compositions and methods of synthesis thereof. The compositions disclosed and described herein are directed toward thyroid hormone ?v?3 integrin receptor antagonists conjugated to targets of the norepinephrine transporter (NET) or the catecholamine transporter. The compositions have a dual targeting effect and increased targeting efficiency in the treatment and diagnostic imaging of neuroendocrine tumors.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: June 25, 2019
    Assignee: NANOPHARMACEUTICALS, LLC.
    Inventors: Shaker Mousa, Mehdi Rajabi, Ozlem O. Karakus